Seniors age 65 years and older can experience a significant reduction in mortality risk when treated with the antiviral drug oseltamivir during influenza hospitalizations, even if they were not vaccinated for flu, according to research involving 8,135 influenza patients that was published in Open Forum Infectious Diseases. Patients who were given oseltamivir had an 18% lower risk of 30-day mortality (hazard ratio [HR], 0.82; 95% confidence interval [CI], 0.69 to 0.98). The overall mortality ratio …
Read More